XBP1 and neoplasm: The mechanisms by which ERS affects tumor-associated DCs have also been elucidated, where changes in the TME leading to the accumulation of unfolded protein induce the activation of ERS and IRE1α–XBP1 signaling, thereby inhibiting their antigen-presenting function [148, 149].